Review





Similar Products

92
MedChemExpress tamibarotene
Tamibarotene, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tamibarotene/Tamibarotene/pm39952330-44-5-50
Average 92 stars, based on 1 article reviews
tamibarotene - by Bioz Stars, 2026-09
92/100 stars
  Buy from Supplier

92
TargetMol tamibarotene
Tamibarotene, supplied by TargetMol, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tamibarotene/Tamibarotene/targetmol___t6694
Average 92 stars, based on 1 article reviews
tamibarotene - by Bioz Stars, 2026-09
92/100 stars
  Buy from Supplier

94
Santa Cruz Biotechnology am80
Am80, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tamibarotene/AM+80/us12514834-172-4-1
Average 94 stars, based on 1 article reviews
am80 - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

am80  (Tocris)
93
Tocris am80
ATF5 is highly localized in the nuclei of human and mouse pancreatic cancer cells in stiff tumors (A) Representative staining images of hematoxylin and eosin (HE) and immunohistochemistry for ATF5 and EGR1 in adjacent normal, and collagen-poor and collagen-rich tumor regions of human pancreatic ductal adenocarcinoma. The areas of black rectangles are magnified. (B) Proportions of cells negative for ATF5 (−), nuclear positive for ATF5 (Nuc(+)), and nuclear negative and cytoplasm-positive for ATF5 (Other(+)) in human pancreatic cancer tissues ( n = 9 patients) were examined via immunohistochemistry, followed by quantification. (C) Proportions of cells negative for EGR1 (−), nuclear-positive for EGR1 (Nuc(+)), and nuclear-negative and cytoplasm-positive for EGR1 (Other(+)) in human pancreatic cancer tissues ( n = 9 patients) were examined by immunohistochemistry, followed by quantification. (D) Representative staining images of hematoxylin and eosin (HE) and immunohistochemistry for ATF5 and EGR1 in control pancreatic tumors and those treated with <t>AM80.</t> The areas of black rectangles are magnified. Note that AM80 is reported to reduce tumor stiffness by inducing changes in the phenotype of CAFs. (E) Proportions of cells negative for ATF5 (−), nuclear positive for ATF5 (Nuc(+)), and nuclear negative and cytoplasm-positive for ATF5 (Other(+)) in tumor tissues obtained from control mice ( n = 9) and those administered AM80 ( n = 10) were examined via immunohistochemistry followed by quantification. (F) Proportions of cells negative for EGR1 (−), nuclear positive for EGR1 (Nuc(+)), and nuclear negative and cytoplasm-positive for EGR1 (Other(+)) on tumor tissues obtained from control mice ( n = 9) and those administered AM80 ( n = 10) were examined via immunohistochemistry followed by quantification. Scale bar = 100 μm; mean with S.D. and each data point is shown; †, statistical significance ( p < 0.05) determined via Student’s t test; ‡, statistical significance ( p < 0.05) determined via Welch’s t-test; ¥, statistical significance ( p < 0.05) determined via Wilcoxon rank-sum test; §, statistical significance ( p < 0.05) determined via paired t-test. For multiple comparisons, we analyzed significance using the Bonferroni correction.
Am80, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tamibarotene/AM+80/pmc11928855-63-0-2
Average 93 stars, based on 1 article reviews
am80 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

90
Ambeed Inc tamibarotene ambeed a197861
ATF5 is highly localized in the nuclei of human and mouse pancreatic cancer cells in stiff tumors (A) Representative staining images of hematoxylin and eosin (HE) and immunohistochemistry for ATF5 and EGR1 in adjacent normal, and collagen-poor and collagen-rich tumor regions of human pancreatic ductal adenocarcinoma. The areas of black rectangles are magnified. (B) Proportions of cells negative for ATF5 (−), nuclear positive for ATF5 (Nuc(+)), and nuclear negative and cytoplasm-positive for ATF5 (Other(+)) in human pancreatic cancer tissues ( n = 9 patients) were examined via immunohistochemistry, followed by quantification. (C) Proportions of cells negative for EGR1 (−), nuclear-positive for EGR1 (Nuc(+)), and nuclear-negative and cytoplasm-positive for EGR1 (Other(+)) in human pancreatic cancer tissues ( n = 9 patients) were examined by immunohistochemistry, followed by quantification. (D) Representative staining images of hematoxylin and eosin (HE) and immunohistochemistry for ATF5 and EGR1 in control pancreatic tumors and those treated with <t>AM80.</t> The areas of black rectangles are magnified. Note that AM80 is reported to reduce tumor stiffness by inducing changes in the phenotype of CAFs. (E) Proportions of cells negative for ATF5 (−), nuclear positive for ATF5 (Nuc(+)), and nuclear negative and cytoplasm-positive for ATF5 (Other(+)) in tumor tissues obtained from control mice ( n = 9) and those administered AM80 ( n = 10) were examined via immunohistochemistry followed by quantification. (F) Proportions of cells negative for EGR1 (−), nuclear positive for EGR1 (Nuc(+)), and nuclear negative and cytoplasm-positive for EGR1 (Other(+)) on tumor tissues obtained from control mice ( n = 9) and those administered AM80 ( n = 10) were examined via immunohistochemistry followed by quantification. Scale bar = 100 μm; mean with S.D. and each data point is shown; †, statistical significance ( p < 0.05) determined via Student’s t test; ‡, statistical significance ( p < 0.05) determined via Welch’s t-test; ¥, statistical significance ( p < 0.05) determined via Wilcoxon rank-sum test; §, statistical significance ( p < 0.05) determined via paired t-test. For multiple comparisons, we analyzed significance using the Bonferroni correction.
Tamibarotene Ambeed A197861, supplied by Ambeed Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tamibarotene/tamibarotene+ambeed+a197861/pmc11868923-38-1-4
Average 90 stars, based on 1 article reviews
tamibarotene ambeed a197861 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


ATF5 is highly localized in the nuclei of human and mouse pancreatic cancer cells in stiff tumors (A) Representative staining images of hematoxylin and eosin (HE) and immunohistochemistry for ATF5 and EGR1 in adjacent normal, and collagen-poor and collagen-rich tumor regions of human pancreatic ductal adenocarcinoma. The areas of black rectangles are magnified. (B) Proportions of cells negative for ATF5 (−), nuclear positive for ATF5 (Nuc(+)), and nuclear negative and cytoplasm-positive for ATF5 (Other(+)) in human pancreatic cancer tissues ( n = 9 patients) were examined via immunohistochemistry, followed by quantification. (C) Proportions of cells negative for EGR1 (−), nuclear-positive for EGR1 (Nuc(+)), and nuclear-negative and cytoplasm-positive for EGR1 (Other(+)) in human pancreatic cancer tissues ( n = 9 patients) were examined by immunohistochemistry, followed by quantification. (D) Representative staining images of hematoxylin and eosin (HE) and immunohistochemistry for ATF5 and EGR1 in control pancreatic tumors and those treated with AM80. The areas of black rectangles are magnified. Note that AM80 is reported to reduce tumor stiffness by inducing changes in the phenotype of CAFs. (E) Proportions of cells negative for ATF5 (−), nuclear positive for ATF5 (Nuc(+)), and nuclear negative and cytoplasm-positive for ATF5 (Other(+)) in tumor tissues obtained from control mice ( n = 9) and those administered AM80 ( n = 10) were examined via immunohistochemistry followed by quantification. (F) Proportions of cells negative for EGR1 (−), nuclear positive for EGR1 (Nuc(+)), and nuclear negative and cytoplasm-positive for EGR1 (Other(+)) on tumor tissues obtained from control mice ( n = 9) and those administered AM80 ( n = 10) were examined via immunohistochemistry followed by quantification. Scale bar = 100 μm; mean with S.D. and each data point is shown; †, statistical significance ( p < 0.05) determined via Student’s t test; ‡, statistical significance ( p < 0.05) determined via Welch’s t-test; ¥, statistical significance ( p < 0.05) determined via Wilcoxon rank-sum test; §, statistical significance ( p < 0.05) determined via paired t-test. For multiple comparisons, we analyzed significance using the Bonferroni correction.

Journal: iScience

Article Title: Stiff extracellular matrix activates the transcription factor ATF5 to promote the proliferation of cancer cells

doi: 10.1016/j.isci.2025.112057

Figure Lengend Snippet: ATF5 is highly localized in the nuclei of human and mouse pancreatic cancer cells in stiff tumors (A) Representative staining images of hematoxylin and eosin (HE) and immunohistochemistry for ATF5 and EGR1 in adjacent normal, and collagen-poor and collagen-rich tumor regions of human pancreatic ductal adenocarcinoma. The areas of black rectangles are magnified. (B) Proportions of cells negative for ATF5 (−), nuclear positive for ATF5 (Nuc(+)), and nuclear negative and cytoplasm-positive for ATF5 (Other(+)) in human pancreatic cancer tissues ( n = 9 patients) were examined via immunohistochemistry, followed by quantification. (C) Proportions of cells negative for EGR1 (−), nuclear-positive for EGR1 (Nuc(+)), and nuclear-negative and cytoplasm-positive for EGR1 (Other(+)) in human pancreatic cancer tissues ( n = 9 patients) were examined by immunohistochemistry, followed by quantification. (D) Representative staining images of hematoxylin and eosin (HE) and immunohistochemistry for ATF5 and EGR1 in control pancreatic tumors and those treated with AM80. The areas of black rectangles are magnified. Note that AM80 is reported to reduce tumor stiffness by inducing changes in the phenotype of CAFs. (E) Proportions of cells negative for ATF5 (−), nuclear positive for ATF5 (Nuc(+)), and nuclear negative and cytoplasm-positive for ATF5 (Other(+)) in tumor tissues obtained from control mice ( n = 9) and those administered AM80 ( n = 10) were examined via immunohistochemistry followed by quantification. (F) Proportions of cells negative for EGR1 (−), nuclear positive for EGR1 (Nuc(+)), and nuclear negative and cytoplasm-positive for EGR1 (Other(+)) on tumor tissues obtained from control mice ( n = 9) and those administered AM80 ( n = 10) were examined via immunohistochemistry followed by quantification. Scale bar = 100 μm; mean with S.D. and each data point is shown; †, statistical significance ( p < 0.05) determined via Student’s t test; ‡, statistical significance ( p < 0.05) determined via Welch’s t-test; ¥, statistical significance ( p < 0.05) determined via Wilcoxon rank-sum test; §, statistical significance ( p < 0.05) determined via paired t-test. For multiple comparisons, we analyzed significance using the Bonferroni correction.

Article Snippet: AM80 , Tocris , Cat# 3507.

Techniques: Staining, Immunohistochemistry, Control

Journal: iScience

Article Title: Stiff extracellular matrix activates the transcription factor ATF5 to promote the proliferation of cancer cells

doi: 10.1016/j.isci.2025.112057

Figure Lengend Snippet:

Article Snippet: AM80 , Tocris , Cat# 3507.

Techniques: Purification, Recombinant, Plasmid Preparation, Modification, Cloning, Transfection, In Vitro, Isolation, Staining, Control, Western Blot, Microarray, shRNA, Software